New Report on Global HIV Market: An Analysis by Koncept Analytics

Feb. 3, 2009 - PRLog -- HIV is a lentivirus and attacks immune system which leads to death. The continuous research has developed treatment for HIV which has made a separate market for HIV drugs.  The HIV drug market is increasing due to increasing awareness and diagnosis rates. There are around five million people in low and middle income countries who do not have access to AIDS drugs. HIV is very common in Southern African region. Botswana and Zimbabwe are the most affected countries; HIV is the most underlying reason for more than one third of all deaths among children under age of five.  

In Japan, unwanted teen pregnancy is rising which may drive HIV drugs market in near future. Also the innovation of new drugs is driving HIV market; research continues to remain a significant unmet medical need for effective treatment.

The report outlines major countries affected from HIV virus and death rates. It also gives an overview of HIV virus and therapies in demand. The report presents overview of global market, HIV in US, UK, Asia and Sub-Saharan Africa. It highlights major markets for HIV drugs with overall market value and major drugs revenue.

The report broadly includes the following

1. Industry Overview          

2. Market Size          

2.1 Global HIV Market          
HIV/AIDS Cases

2.2 United States HIV Market        
HIV/AIDS Cases by Region
AIDS Diagnoses

2.3 Sub-Saharan Africa HIV Market
2.4 United Kingdom HIV Market      
Diagnosed Cases
HIV Infected Persons by Region

2.5 Asian HIV Market

3. HIV Drugs Market            

Market Value
Drug Revenue Comparison

4. Market Trends      

4.1 Opportunities in HIV Drug Market        
4.2 Key Issues        

5. Major Market Players    

5.1 Competition        
Major Players Growth Comparison

5.2 Company Profiles

5.2.1 Gilead Science
5.2.2 Idenix Pharmaceuticals
5.2.3 Bristol Myers Squibb    

6. Market Forecast  
People Receiving Therapy Projections

List of Tables

Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Protease Inhibitors (PIs)
HIV/AIDS Worldwide Cases/Deaths (2007)
US AIDS Diagnosis (2006)
Transmission Category of HIV (2006)
Sub-Saharan Africa Cases/Deaths (2007)
HIV/AIDS Diagnosed Cases in UK by Gender (2000-08)
HIV/AIDS Diagnosed Cases in UK by Region (2000-08)
China AIDS Statistics (2007)
Major Players Growth Comparison (2007)
Gilead Revenue by Geography (2005-07)
Idenix Revenue by Products (2006-07)
Bristol-Myers Squibb Revenue by Business Segments (2005-07)
First-line Therapy Projections (2008-13E)
People Receiving Antiretroviral Therapy (2006-08E)

List of Charts

Worldwide HIV/AIDS Cases (2006)
Children Living with HIV Globally (2007)
Top Ten Reported AIDS Cases in US by Region (2006)
HIV Prevalence in Pakistan by Region (2007)
Global HIV Drugs Market (2004-07)
Global HIV Drugs Revenue Comparison (2006)
Global HIV Drugs Revenue Comparison (2007)
Ranking of America’s Largest Pharma Corporations (2007)
Top Biotechnology Companies (2006)

For more details, please visit http://www.konceptanalytics.com/reportDetail.aspx?reportI...

To know more about us http://www.konceptanalytics.com

# # #

Koncept Analytics, founded in 2005, works with the clients in developing an understanding of the various industries – segments and sub-segments, companies, competitors and suppliers.